This Week in Digital Health Funding
Atlas Venture, DNAnexus, Sherlock Biosciences, Health Gorilla, Homeward, Kuma Partners & More
Uganda’s Rocket Health raises $5M in a round led by Creadev to scale #telemedicine across Africa – TechCrunch https://techcrunch.com/2022/03/07/ugandas-rocket-health-raises-5m-in-round-led-by-creadev-to-scale-telemedicine-across-africa/
Austin's MDisrupt Lands $6 Million in Seed Funding to Build Its Digital Health Intelligence Platform - Company expands its offerings with a mission to organize #digitalhealth products that enable patients and their providers to make objective, data-driven decisions about their healthcare” https://www.businesswire.com/news/home/20220307005352/en/MDisrupt-Lands-6-Million-in-Seed-Funding-to-Build-Its-Digital-Health-Intelligence-Platform
Homeward launches with $20M to create greater access to rural healthcare - The company combines telehealth, RPM, and an on-the-ground care team for people in rural areas. https://homewardhealth.com/blog/homeward-launch
Remote patient monitoring company Curv Health raises $5.1M - The company works with employers and providers to connect their members to physicians. https://www.curvhealth.com/
Vivante Health, the leading digital solution for digestive health and disease, raises $16M in Series A Round Led by 7wireVentures. https://thisweekindigitalhealth.com/vivante-health-raises-16m/
Maverick Medical AI Closes $5M to Improve Medical Coding - Accelerating Development of its mCoder™ Artificial Intelligence Platform. https://thisweekindigitalhealth.com/maverick-medical-ai-closes-5m-to-improve-medical-coding/
Health Gorilla has raised $50 M. SignalFire led joined by Epsilon, IA Capital, and Nationwide Ventures - the San Francisco-based data-sharing platform that allows healthcare organizations, payers, providers, labs to exchange clinical data with one another. https://www.mobihealthnews.com/news/interoperability-startup-health-gorilla-scores-50m-and-more-digital-health-fundings
DNAnexus, a Mountain View, Ca.-based company that makes biomedical data analysis software, has raised $200 million in funding led by Blackstone. Earlier backers also joined the round, including Northpond Ventures, GV, Perceptive Advisors, Innovatus Capital Partners, and Foresite Capital. https://www.fiercebiotech.com/medtech/gv-backed-dnanexus-snags-200m-build-out-genomic-data-analytics-platform
CancerIQ, a Chicago-based precision medicine startup, raised $14 million in funding co-led by Merck and Amgen. Other investors in the round included McKesson Ventures, OSF Ventures, and HealthX Ventures. https://hitconsultant.net/2022/03/03/canceriq-cancer-prevention-funding/
Kuma Partners, a Paris-based health and biotech venture firm, says it has held a first close with €160 million in capital commitments for a growth fund that it expects to close with €250 million altogether. https://www.businesswire.com/news/home/20220307005977/en/Kurma-Partners-Targets-%E2%82%AC250-Million-for-Its-First-Growth-Opportunities-Fund
Microbiotica, an England-based company that's developing bacterial therapies and biomarkers using the human microbiome -- a source of trillions of microorganisms that exist in the body -- has raised $67 million in Series B funding. The Swedish life science investor Flerie co-led the round with China-based Tencent. https://www.fiercebiotech.com/biotech/microbiotica-nabs-67-million-series-b-push-microbiome-therapies-through-clinic
Adiso Therapeutics, a newly launched, Concord, Ma.-based biotech focused on inflammatory diseases that are the product of two biotechs -- an Irish microbiome business and a U.S. neutrophil biology specialist -- that investor Morningside Ventures rolled up, has raised more than $60 million from the Hong Kong-based Morningside. https://www.fiercebiotech.com/biotech/morningside-rolls-pair-biotechs-birth-clinical-phase-inflammatory-disease-player
Dallas-based biotech that's trying to use ancient genetic material to create modern-day versions of woolly mammoths to fight climate change and advance health care, Colossal has raised $75 M. The company is headed by famed Harvard University geneticist George Church and tech entrepreneur Ben Lamm. Thomas Tull and At One Ventures co-led the round, joined by Untamed Planet, Animoca Brands, Breyer Capital, Animal Capital, Bold Capital, and Paris Hilton. https://www.bloomberg.com/news/articles/2022-03-09/woolly-mammoth-revival-raises-75-million-from-vc-firms-paris-hilton
San Diego-based developer of RNA-based medicines and their components, Creyon Bio has raised $40 million in combined seed and Series A funding. DCVC Bio and Lux Capital are the outfit's biggest investors; others of its backers include Casdin Capital, Alexandria Venture Investments, and BioBrit. https://creyonbio.com/
Vietnam-based omnichannel health care startup whose online and offline care services are integrated with its lab information systems, e-pharmacy, and clinical operating systems, Jio Health has raised $20 million in Series B funding. Heritas Capital led the round, joined by Fuchsia VC, Kasikorn Bank Group, and Monk’s Hill Ventures. https://www.techinasia.com/vietnamese-healthcare-startup-banks-20m-series
Bay Area-based pregnancy care platform featuring real-time monitoring, Delfina has raised $5.3 M led by Story Ventures with SemperVirens VC, Bread & Butter Ventures, Goodwater Capital, MIT E14 Fund, Metrodora VC, and SpringTime Ventures. https://femtechinsider.com/delfina-seed-round/
New York-based, subscription-based reproductive support startup that aims to offer at-home testing, precision nutrition, and digital care plans, Noula Health raised $1.4 million in seed funding from Muse Capital and Precursor Ventures. https://www.axios.com/noula-seed-financing-closes-d9ce5f27-c95e-48da-b2bf-8236210ac8e3.html
Pittsburgh, Pa.-based maker of a vibrating wearable wristband for stress reduction, Apollo Neuro has raised $15 million in a Series A funding led by Noetic Fund. https://apolloneuro.com/
Zeta Surgical, a 3.5-year-old, Boston-based startup aiming to deliver precise surgical imaging guidance for non-invasive surgeries performed outside the operating room, has raised $5.2 million in seed funding led by Innospark Ventures. https://techcrunch.com/2022/03/10/zeta-surgical-comes-out-of-stealth-with-a-5-75m-raise-for-image-guided-surgery/
Sherlock Biosciences, a three-year-old, Boston-based CRISPR diagnostics startup, has raised $80 million in Series B funding led by Novalis LifeSciences. Other investors in the round include Illumina Ventures, Albany Capital, Catalio Capital Management, and earlier backers Northpond Ventures and Good Ventures. https://www.fiercebiotech.com/medtech/sherlock-biosciences-unearths-80m-bring-crispr-based-tests-home
Boston-based e-commerce platform for health care payments, Lynx has raised $15 million in Series A funding co-led by Obvious Ventures and .406 Ventures, Other backers in the round included Frist Cressey Ventures, Winter Street Ventures, Shields Capital and Huntington Avenue Ventures. https://www.lynx-fh.com/
HealthHouston, Tex.-based developer of virtual tools for digestive care, Vivante has raised $16 million in Series A funding led by 7wireVentures. https://www.axios.com/vivante-health-digestive-care-tech-7wireventures-3151b3f4-bcd3-47c0-9e0c-f6122702c578.html
Boston-based venture firm focused on life sciences companies, Atlas Venture has closed its 13th early-stage fund with $450 million for #biotech https://www.fiercebiotech.com/biotech/atlas-lands-450m-fund-build-fresh-batch-biotechs
Minneapolis-based provider of in-home and virtual primary care services, Nice Healthcare just raised $30 million in Series A funding. DNA Capital led the round. https://buff.ly/367oUti
Amsterdam-based biotech focused on genetic modifiers, Scenic Biotech has raised €31 million in Series A funding from Eir Ventures, BioMedPartners, Vesalius Biocapital, and earlier backers. https://www.fiercebiotech.com/biotech/roche-partnered-scenic-biotech-snags-31m-study-three-rare-disease-drugs
San Francisco-based pharmacy benefits management startup, SmithRx has raised $20 million in Series B funding led by Venrock, with participation from Founders Fund. https://www.axios.com/venrock-seriesb-smithrx-20-million-fbe764bd-ce04-478d-8af4-80154d375c19.html
New York-based developer of #AI tools to monitor psychiatric and neurological disorders, @behavidence just raised $4.3 million in seed funding led by Welltech Ventures, with participation from Arc Impact and Longevity Ventures. https://aithority.com/machine-learning/behavidence-closes-4-3-million-seed-round-to-amplify-its-artificial-intelligence-technology-used-to-detect-screen-and-monitor-mental-illness/